Brian Till, MD

Assistant Member
Clinical Research Division
Assistant Professor, Medicine
University of Washington
Attending Physician, Stem Cell Transplant Service
Seattle Cancer Care Alliance


University of Chicago, 2002, MD

Research Focus:

Dr. Till is developing new immunotherapies for lymphoma, focusing on the approach of adoptive T cell therapy with autologous T lymphocytes genetically engineered to express a chimeric antigen receptor (CAR). Dr. Till, in collaboration with Dr. Press, is planning a clinical trial in patients with lymphoma to test these cells, which will also express a “suicide” gene that allows the cells to be killed in case they cause toxicities or other problems. Dr. Till’s laboratory is also exploring the effects of co-inhibition and co-stimulation on CAR T cells.

Clinical Expertise:

Dr. Till’s clinical expertise is in lymphoma as well as autologous stem cell transplantation.

Related News

Additional Links & Information

Related Labs & Projects

View all labs & projects >
Brian Till, MD

Contact Information

(206) 667-7269
(206) 667-1874
Additional contact

Mailstop: D3-190